High glucose suppresses expression of equilibrative nucleoside transporter 1 (ENT1) in rat cardiac fibroblasts through a mechanism dependent on PKC‐ζ and MAP kinases
- 16 October 2007
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 215 (1), 151-160
- https://doi.org/10.1002/jcp.21296
Abstract
Recently it was demonstrated that the elevated concentration of glucose but not lack of insulin is responsible for suppression of equilibrative nucleoside transporter (ENT1) in diabetic rat cardiac fibroblasts (CFs). The present study was undertaken to determine the signaling pathway utilized by glucose to regulate the expression of ENT1 in the primary culture of rat CFs. Pretreatment of CFs with Go 6983, an isozyme non-selective PKC inhibitor, prevented the high glucose (25 mM) effect on ENT1 mRNA level and nitrobenzylthioinosine (NBTI)-sensitive adenosine uptake. Similar effect was observed with a cell-permeable PKC-ζ pseudosubstrate, whereas Go 6976 a selective inhibitor of Ca2+-dependent PKC-α and PKC-β isozymes had little effect on high glucose-induced suppression of ENT1 mRNA level. Incubation of CFs with nitric oxide (NO) donors (SNAPE, SNP) or NO synthase inhibitors (L-NAME, L-NMMA) prior to exposition of CFs to high glucose did not change the glucose effect on ENT1 mRNA level. The high glucose-induced suppression of ENT1 expression was blocked by PD9859 (an inhibitor of MEK), whereas neither wortmannin (an inhibitor of PI3K) nor rapamycin (an inhibitor of mTOR) affected the glucose action on ENT1 transcript level. Highly effective in preventing the high glucose effect on ENT1 mRNA level were GW 5074 (an inhibitor of Raf kinase) and SB 203580 (selective p38 MAPK inhibitor). These findings indicate that high glucose suppresses the expression of ENT1 in CFs by NO independent manner involving the signaling through PKC-ζ, Raf-1, MEK, and p38 MAPK pathways. J. Cell. Physiol. 215: 151–160, 2008.Keywords
This publication has 72 references indexed in Scilit:
- Different signaling pathways utilized by insulin to regulate the expression of ENT2, CNT1, CNT2 nucleoside transporters in rat cardiac fibroblastsArchives of Biochemistry and Biophysics, 2007
- Diabetes Alters Sphingolipid Metabolism in the RetinaDiabetes, 2006
- Reduced ability to release adenosine by diabetic rat cardiac fibroblasts due to altered expression of nucleoside transportersThe Journal of Physiology, 2006
- The Pathogenesis of Myocardial Fibrosis in the Setting of Diabetic CardiomyopathyJournal of the American College of Cardiology, 2006
- Differential effect of insulin and elevated glucose level on adenosine transport in rat B lymphocytesInternational Immunology, 2004
- Opposing effects of δ- and ζ-protein kinase C isozymes on cardiac fibroblast proliferation: use of isozyme-selective inhibitorsJournal of Molecular and Cellular Cardiology, 2003
- Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion.JCI Insight, 1998
- Restoration of nitric oxide production by aldose reductase inhibitor in human endothelial cells cultured in high-glucose mediumLife Sciences, 1996
- Inhibition of protein kinase C μ by various inhibitors. Inhibition from protein kinase c isoenzymesFEBS Letters, 1996
- PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in VivoPublished by Elsevier BV ,1995